Supernus Pharmaceuticals | GJELD



Debt Endring Dato
Abbott USD 13.24B 883M 2025-03
ANI Pharmaceuticals USD 624.09M 304.02M 2024-12
Aurora Cannabis CAD 100.98M 11K 2024-12
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Canopy Growth CAD 489.67M 123.85M 2024-12
Corcept Therapeutics USD 0 0 2024-12
Eisai JPY 219.1B 36.2B 2024-12
Eli Lilly USD 38.52B 4.87B 2025-03
Indivior 329M 4M 2025-03
Novo Nordisk 56.97B 88M 2024-09
Pacira USD 585.32M 2.04M 2024-12
Perrigo USD 3.62B 1.14B 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Supernus Pharmaceuticals USD 0 0 2024-12
United Therapeutics USD 200M 100M 2025-03
Xeris Pharmaceuticals USD 247.21M 15.93M 2024-12



Supernus Pharmaceuticals GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2025.